# Element Biosciences said on Tuesday it had raised funds in an upsized Series ‌E round.

*biotech, business · news · 2026-06-09 · The Star*

## Key points

- Element Biosciences raised $175 million from Samsung Electronics in an upsized Series E round.
- The funding will support commercialization of AVITI, VITARI, AVITI Dx, and AVITI24 products.
- Element aims to use the new capital to expand internationally and develop future diagnostic products.
- Financing terms, including total round size and company valuation, were not disclosed.

June 9 (Reuters) - Privately ⁠held Element Biosciences said on Tuesday it ⁠had raised funds in an upsized Series ‌E round, including $175 million from longtime investor Samsung Electronics, to expand commercialization of its genetic testing and research products. The San ​Diego-based company did not disclose ⁠the total size ⁠of the round or its valuation. It also did ⁠not ‌name the other investors. Element said the financing would support commercialization of its ⁠sequencing products, such as AVITI and VITARI, ​as well ‌as the upcoming launches of AVITI Dx ⁠and AVITI24. The ​AVITI sequencing system is benchtop gene-sequencing equipment that decodes DNA and RNA for applications including medical ⁠research, disease detection and drug development. In ​the gene-sequencing market, Illumina remains the dominant player, while Roche has been expanding its footprint through ⁠partnerships and investments in next-generation sequencing and molecular diagnostics. Element said the funding would also help expand its international presence and support development of ​future products for research, drug ⁠development and diagnostic uses. The financing is subject to ​regulatory approval. The new financing follows ‌Element's $277 million Series D round ​announced in July 2024. (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Shreya Biswas)

**Companies:** Samsung Electronics, Element Biosciences
**Countries:** United States, South Korea

[Read the full story on The Star](https://www.thestar.com.my/tech/tech-news/2026/06/10/samsung-electronics-invests-175-million-in-element-biosciences039-series-e-funding-round)

---

Canonical: https://newsio.io/n/cb4d833f-f674-4f70-a7c4-1728845ba5bc/element-biosciences-said-on-tuesday-it-had-raised-funds-in-an-upsized-series-e-r
Summarized by Newsio from The Star. https://newsio.io/how-it-works